Moxiclav Bis (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, which halts peptidoglycan cross‑linking. Clavulanic acid is a beta‑lactamase inhibitor that binds irreversibly to bacterial beta‑lactamases, protecting amoxicillin from enzymatic degradation and allowing it to remain effective against resistant strains.

The exact dose is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and renal function. Standard adult regimens often range from 500 mg/125 mg to 875 mg/125 mg taken every 8–12 hours, but the prescriber will set the appropriate schedule for each individual case.

Safety data for amoxicillin‑clavulanic acid in pregnancy and lactation are limited, and the product does not have a definitive pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Amoxicillin alone is vulnerable to degradation by bacterial beta‑lactamases, which can limit its effectiveness against resistant organisms. Adding clavulanic acid inhibits those enzymes, broadening the spectrum to include beta‑lactamase‑producing strains such as Haemophilus influenzae and certain Staphylococcus species, making Moxiclav Bis a more versatile option for mixed infections.

Moxiclav Bis should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

The medication is administered orally. Tablets should be swallowed whole with a full glass of water and may be taken with or without food, unless the prescribing information advises otherwise. The exact dosing interval is set by the prescriber.

Serious adverse events include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hepatic enzyme elevations, neutropenia, and rare skin disorders like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience difficulty breathing, severe rash, persistent diarrhea, or jaundice.

Moxiclav Bis is contraindicated in individuals with a known hypersensitivity to any penicillin, beta‑lactam antibiotics, or clavulanic acid. It should also be avoided in patients who have previously experienced severe allergic reactions to similar drugs. Clinicians should assess each patient’s medical history before prescribing.